Bridge financing of around CHF 6.1 million secures the internationalization step and creates the conditions for institutional funding.
InnoMedica's Board of Directors has decided to carry out a public capital increase to be published in the Swiss Official Gazette of Commerce on 18 November 2024, with a subscription period until 13 December 2024. A maximum of 872,553 new registered shares are to be placed for CHF 7.00 per share, with the subscription rights of existing shareholders being maintained.
The business information update can be ordered using a form.
Download subscription form
Download annual report 2023
Download annual report 2022
Annual Report annual report 2021
Download issue prospectus